CD21 Antikörper (AA 729-957)
-
- Target Alle CD21 (CR2) Antikörper anzeigen
- CD21 (CR2) (Complement Component (3d/Epstein Barr Virus) Receptor 2 (CR2))
-
Bindungsspezifität
- AA 729-957
-
Reaktivität
- Human
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser CD21 Antikörper ist unkonjugiert
-
Applikation
- Immunohistochemistry (IHC), Western Blotting (WB), Immunoprecipitation (IP), Immunofluorescence (fixed cells) (IF/ICC)
- Aufreinigung
- Antigen-specific affinity chromatography followed by Protein A affinity chromatography
- Immunogen
- Recombinant CR2 (Lys729-Ser957) expressed in E. coli.
- Top Product
- Discover our top product CR2 Primärantikörper
-
anti-Complement Component (3d/Epstein Barr Virus) Receptor 2 (CR2) (AA 142-240) antibody
CR2 Reaktivität: Human FACS, IHC, WB, ELISA, IF, StM, Coat Wirt: Maus Monoclonal CR2-2754 unconjugated
anti-Complement Component (3d/Epstein Barr Virus) Receptor 2 (CR2) antibodyCR2 Reaktivität: Human FACS, IHC, WB, ELISA, IF Wirt: Kaninchen Monoclonal 16F10 unconjugated Recombinant Antibody
anti-Complement Component (3d/Epstein Barr Virus) Receptor 2 (CR2) antibodyCR2 Reaktivität: Human WB, IF Wirt: Kaninchen Monoclonal unconjugated
anti-Complement Component (3d/Epstein Barr Virus) Receptor 2 (CR2) (AA 740-964) antibodyCR2 Reaktivität: Human FACS, WB, ELISA Wirt: Maus Monoclonal 2D2H6 unconjugated
anti-Complement Component (3d/Epstein Barr Virus) Receptor 2 (CR2) (AA 300-590) antibodyCR2 Reaktivität: Human IHC, WB, IF Wirt: Kaninchen Polyclonal unconjugated
anti-Complement Component (3d/Epstein Barr Virus) Receptor 2 (CR2) antibodyCR2 Reaktivität: Human, Schwein, Rind (Kuh), Hund FACS, IHC (fro) Wirt: Maus Monoclonal LT21 unconjugated
anti-Complement Component (3d/Epstein Barr Virus) Receptor 2 (CR2) (AA 981-1092) antibodyCR2 Reaktivität: Human, Ratte FACS, WB, ELISA, IHC (p) Wirt: Kaninchen Polyclonal unconjugated
anti-Complement Component (3d/Epstein Barr Virus) Receptor 2 (CR2) antibodyCR2 Reaktivität: Human, Maus, Ratte IHC, IF Wirt: Kaninchen Polyclonal unconjugated
anti-Complement Component (3d/Epstein Barr Virus) Receptor 2 (CR2) (AA 142-240) antibodyCR2 Reaktivität: Human FACS, IHC, WB, IF, StM Wirt: Kaninchen Monoclonal CR2-3124R unconjugated Recombinant Antibody
anti-Complement Component (3d/Epstein Barr Virus) Receptor 2 (CR2) (AA 44-196) antibodyCR2 Reaktivität: Human IHC, ELISA, StM, Coat Wirt: Maus Monoclonal CR2-1952 unconjugated
-
- Applikationshinweise
- Optimal working dilution should be determined by the investigator.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Konzentration
- 500 μg/mL
- Buffer
- PBS, pH 7.4, containing 0.02 % Sodium azide, 50 % glycerol.
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- 4 °C,-20 °C
- Informationen zur Lagerung
- Store at 4 °C for frequent use. Aliquot and store at -20 °C for one year. Avoid repeated freeze/thaw cycles.
-
- Target
- CD21 (CR2) (Complement Component (3d/Epstein Barr Virus) Receptor 2 (CR2))
- Andere Bezeichnung
- Complement Receptor 2 (CR2 Produkte)
- Synonyme
- C3DR antikoerper, CD21 antikoerper, CR antikoerper, CVID7 antikoerper, SLEB9 antikoerper, Cd21 antikoerper, cd21 antikoerper, CR1 antikoerper, CR1-L antikoerper, CR2 antikoerper, complement C3d receptor 2 antikoerper, complement C3b/C4b receptor 1 (Knops blood group) antikoerper, CR2 antikoerper, Cr2 antikoerper, CR1 antikoerper
- UniProt
- P20023
- Pathways
- Komplementsystem
-
